IBRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ImmunityBio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$8.42−0.76 (-8.28%)
Close on Oct 19, 2026
- Market cap
- $8.84B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of ImmunityBio's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 14, 2026 | Oct 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 10, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 9, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 9, 2026 | Apr 9, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 6, 2026 | Apr 6, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 31, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 23, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2026 | Jan 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2026 | Jan 14, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2025 | Dec 29, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 15, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2025 | Jul 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2025 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2025 | Apr 8, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 19, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 7, 2025 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 7, 2025 | Feb 7, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 11, 2024 | SEC EDGAR |